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Carotid plaque echogenicity is associated with the risk of cardiovascular events. Gray-scale
median (GSM) of the ultrasound image of carotid plaques has been widely used as an objec-
tive method for evaluation of plaque echogenicity in patients with atherosclerosis. We pro-
posed a computer-aided method to evaluate plaque echogenicity and compared its efficiency
with GSM.
Methods
One hundred and twenty-five carotid plaques (43 echo-rich, 35 intermediate, 47 echolucent)
were collected from 72 patients in this study. The cumulative probability distribution curves
were obtained based on statistics of the pixels in the gray-level images of plaques. The area
under the cumulative probability distribution curve (AUCPDC) was calculated as its integral
value to evaluate plaque echogenicity.
Results
The classification accuracy for three types of plaques is 78.4% (kappa value, κ = 0.673),
when the AUCPDC is used for classifier training, whereas GSM is 64.8% (κ = 0.460). The
receiver operating characteristic curves were produced to test the effectiveness of AUCPDC
and GSM for the identification of echolucent plaques. The area under the curve (AUC) was
0.817 when AUCPDC was used for training the classifier, which is higher than that achieved
using GSM (AUC = 0.746). Compared with GSM, the AUCPDC showed a borderline associ-
ation with coronary heart disease (Spearman r = 0.234, p = 0.050).
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Conclusions
Our experimental results suggest that AUCPDC analysis is a promising method for evalua-
tion of plaque echogenicity and predicting cardiovascular events in patients with plaques.
Introduction
Cardiovascular diseases significantly threaten human health and are the primary cause of
death and disability worldwide [1]. Most myocardial infarctions, strokes, and acute coronary
syndromes are caused by the rupture of unstable atherosclerotic plaques [2]. In recent years,
growing evidence has been presented to support the association between plaque echogenicity
and its vulnerability [3,4]. Echolucent plaques are dominated with lipid content, less calcifica-
tion, less fibrous tissue, and tend to be more prone to rupture [5,6]. In addition, previous stud-
ies have demonstrated that plaque echolucency is associated with coronary events and future
stroke [7,8]. Therefore, it is of significant interest to evaluate the plaque echogenicity, which
may contribute to the identification of unstable plaques and for predicting cardiovascular
events.
It is well-known that ultrasound imaging is a non-invasive technique for carotid atheroscle-
rosis plaque examination. Ultrasound measurement of plaque echogenicity can provide a risk
factor for predicting cardiovascular events [9–11]. Visual classification has been used to assess
the plaque echogenicity in many previous studies [11–13], however, the results are operator-
dependent. Recent studies have shown that computer assisted methods of plaque characteriza-
tion using B-mode images can provide measurements in predicting clinical outcome [4,14–
19]. Percentage white (PW) has been proposed as a metric for evaluation of echogenicity in
carotid plaques, but it needs an intensity threshold to determine which pixels are echogenic
(white) [14]. The process of PW feature extraction is relatively complex because the intensity
threshold of each image is different. Texture analysis has been utilized to characterize carotid
atherosclerotic plaques in symptomatic and asymptomatic patients [15–17], and it shows
promise in the assessment of plaque echogenicity by combining the morphological character-
istics of plaques [20]. However, the extraction of texture features requires high computational
complexity. Recent studies have indicated that computerized measurement of the gray-scale
median (GSM) is an objective and useful metric for assessment of the plaque echogenicity
[4,18,19]. It is worthwhile noting that GSM is the fiftieth percentile of the probability distribu-
tion of gray-scale pixels, and it ignores the details of the probability distribution of plaques.
Shankar et al. proposed a method to model the statistics of the pixels in the gray-level images
of soft and hard plaques [21]. The cumulative probability distribution curves showed signifi-
cant trends for these two types of plaques. Therefore, we suggest that the area under the cumu-
lative probability distribution curve (AUCPDC) may be an effective parameter for evaluating
plaque echogenicity.
The aim of this study is to examine whether the AUCPDC analysis is a useful method for
the evaluation of plaque echogenicity and to further compare its efficiency with GSM.
Subjects and methods
A. Patients
The study protocol was approved by the Institutional Review Board of the third affiliated
hospital of Sun Yat-sen University (Guangzhou, China). All participants provided written
informed consent.
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From September 2013 to March 2016, a total of 130 carotid plaques were collected from 74
volunteers, and 5 controversial plaques were excluded after visual classification by two sonog-
raphers. The remaining 125 carotid plaques (43 echo-rich, 35 intermediate and 47 echolucent
plaques) from 72 volunteers were used in the in the following analysis.
B. Clinical and biochemical analyses
Blood samples were collected after an overnight fast for analysis of total cholesterol, triglyc-
eride, high density lipoprotein cholesterol, low density lipoprotein cholesterol, apolipopro-
tein A1, apolipoprotein B100, fasting plasma glucose, and HbA1c. The diagnostic criteria for
hypertension was defined as systolic blood pressure  130 mmHg and/or diastolic blood
pressure  80 mmHg or current use of antihypertensive agents. Diabetes was defined as
fasting plasma glucose level of  7.0 mmol/L, and/or 2-hour plasma glucose value of 11.1
mmol/L, and/or HbA1c level of 6.5%, and/or treatment with either hypoglycemic agents
or insulin [22,23].
C. Images acquisition and preprocessing
Ultrasound images of carotid plaques were collected by a sonographer that has 5 years of expe-
rience in vascular imaging using an Aplio XG (SSA-790A) (Toshiba Medical Systems, Japan)
equipped with a 5–12 MHz linear-array transducer (PLT-805AT). The carotid artery was
examined with the head tilted slightly upward in the mid-line position. The transducer was
manipulated so that the near and far walls were parallel to the transducer footprint, and the
lumen diameter was maximized in the longitudinal plane.
According to the criteria of the European carotid plaque study group, plaques were classi-
fied into three different types: echolucent, intermediate and echo-rich plaques [12]. The visual
classification of plaque echogenicity was independently performed by two sonographers with
at least 5 years of experience in vascular imaging, and a kappa value (κ) was calculated to evalu-
ate the between-observer agreement.
D. Image normalization
The ultrasound system settings (e.g. system gain, time gain compensation etc.) can impact the
brightness and contrast of the B-mode images. In this study, all images were normalized
according to the scheme proposed by Sabetai et al [24]. After normalization, the GSM of the
blood range from 0 to 5, whereas the GSM of adventitia range from 185 to 195.
E. Statistics of the pixels in gray-level images of plaques
In this study, the plaque was manually segmented by one operator in the gray-level image, and
the statistics of the pixels of plaques were obtained. Then, the AUCPDC analysis and GSM
analysis were performed for each plaque based on their pixel statistics.
F. Gray-scale median
Here, we let x represents the gray scale pixel value, f(x) is the probability density function of x,
and f(x) can be calculated as follows:
f ðxÞ ¼
The number of pixels ðgray value ¼ xÞ
Total number of pixels ðgray value range from 0 to 255Þ
: ð1Þ
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where f(x) is defined in Eq (1). A direct expression of GSM is shown in Fig 1B.
G. Area under cumulative probability distribution curve
For each plaque, the cumulative distribution function F(x) of the gray scale distribution, can




f ðxÞ x ¼ 0; 1; 2; . . . ; 254; 255: ð3Þ





Fig 1C illustrates the AUCPDC (shaded area).
H. Classification
The k-nearest-neighbor (KNN) classification was performed for classifying the three different
types of plaques based on AUCPDC or GSM. In order to improve the reliability of classifica-
tion, a leave-one-out cross validation was implemented in this study. The kappa statistic (κ)
was calculated to evaluate the agreement between visual classification and the KNN classifica-
tion. Furthermore, the receiver operating characteristic (ROC) curves for the KNN classifier
were developed to compare the ability of AUCPDC and GSM in identifying echolucent
plaques.
I. Intra-operator agreement
In order to examine the intra-operator agreement, the AUCPDC analyses were performed at
two different times within a 2-month period. Based on the same visual classification, a total of
Fig 1. The GSM and AUCPDC of representative image of plaque. (a) Representative image of plaque; (b) When the orange area is 0.5, the horizontal
coordinate value is GSM of the plaque illustrated in (a); (c) the shaded areas are the AUCPDC of the plaque illustrated in (a). Note that GSM = gray-scale
median; AUCPDC = area under cumulative probability distribution curve.
https://doi.org/10.1371/journal.pone.0185261.g001
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45 plaques (15 echolucent, 15 intermediate and 15 echo-rich plaques) were randomly selected
from the same original images, and the manual plaque segmentation was carried out again by
the same operator. The intra-operator agreement was evaluated according to the method pro-
posed by Bland and Altman [25].
J. Bootstrapping for estimating Youden’s index J
Youden’s index J [26] is a single statistic that can summarize the performance of a diagnostic
test, and it is defined as:
J ¼ sensitivity þ specificity   1: ð5Þ
It has been widely utilized in many studies to evaluate the accuracy of diagnostic tests and the
performance of risk assessment model [27,28].
Bootstrap is a useful tool to provide statistical inference to estimate the accuracy and the
precision of any statistic through resampling with replacement from the original datasets
[29,30]. In this study, the bootstrapping is implemented to estimate the 95% confidence inter-
vals (CIs) of Youden’s index J.
K. Statistical analyses
All statistical analysis was performed with PASW Statistics 18 and all values were presented as
the mean value ± SD, or real number of patients with the percentage in parentheses.
Spearman’s rank correlation analysis was also implemented between the GSM, AUCPDC and
the status of hypertension, diabetes, coronary heart disease (CHD). Youden’s index J was cal-
culated using MedCalc statistical software.
Results
A. Patient characteristics
The baseline characteristics of the study population are shown in Table 1. Among a total of 72
patients (51 male, 70.1%; age, 69.7 ± 8.7 years), 46 (63.9%) patients had hypertension, 31
(43.1%) had diabetes and 27 (37.5%) had CHD.
B. Visual classification
The classification of the carotid plaques (n = 130) into three different types showed a good
agreement between two experienced sonographers (Table 2). The between-observer reproduc-
ibility was 96.15% (κ = 0.942). A total of 5 controversial plaques were excluded, and the 125
consensual plaques were retained in the following analysis.
C. The area under cumulative probability distribution curve of plaque
Fig 2 shows the AUCPDC analysis of representative echoluent, intermediate and echo-rich
plaques. The AUCPDC of echolucent plaques were largest, followed by intermediate plaques
and echo-rich plaques (Fig 2D). The AUCPDC showed a statistical significance among the
echo-rich, intermediate, echolucent plaques (130 ± 22 vs. 177 ± 18 vs. 207 ± 21, p< 0.001).
When type 1 denoted echo-rich, type 2 intermediate type 3 echolucent, the mean AUCPDC
had a correlation with the types of plaques (Spearman r = -0.856, p< 0.001).
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D. Carotid plaque classification
As shown in Tables 3 and 4, when AUCPDC was used for training classifier, the classification
accuracy of discriminating the echo-rich, intermediate and echolucent plaques was 78.4% (κ =
0.673), which was higher than that obtained by using GSM 64.8% (κ = 0.460). When classifica-
tion based on GSM, 8 of 35 intermediate plaques were classified correctly, and 21 of 35 inter-
mediate plaques were misclassified as echolucent plaques (Table 3). The AUCPDC was more
effective in discriminating intermediate and echolucent plaques than GSM. Table 4 indicated
that 21 of 35 intermediate plaques were classified correctly, and 11 of 35 intermediate plaques
were misclassified as echolucent plaques, when classification based on AUCPDC. Further,
ROC curve analysis was developed to test the effectiveness of AUCPDC in the identification of
echolucent plaques. The area under the curve (AUC) was 0.817 when AUCPDC was used for
training the classifier, whereas AUC was 0.746 when GSM was used (Fig 3).
Table 1. Baseline characteristics of 72 patients.
Characteristics Total (n = 72)
Age, mean (SD) 69.7 ± 8.7
Male gender, n (%) 51 (70.1)
Hypertension, n (%) 46 (63.9)
Smoking, n (%) 29 (40.3)
Diabetes, n (%) 31 (43.1)
CHD, n (%) 27 (37.5)
SBP (mm Hg) 136.5 ± 22.9
DBP (mm Hg) 77.0 ± 12.5
BMI (kg/m2) 22.2 ± 2.7
TC (mmol/L) 4.26 ± 1.12
TG (mmol/L) 1.43 ± 1.14
HDL-C (mmol/L) 1.04 ± 0.27
LDL-C (mmol/L) 2.66 ± 0.95
ApoA1 (g/L) 1.19 ± 0.29
ApoB100 (g/L) 1.06 ± 0.38
FBG (mmol/L) 6.65 ± 2.87
HbA1c (%) 6.31 ± 1.84
CHD = coronary heart disease; SBP = systolic blood pressure; DBP = diastolic blood pressure; BMI = body
mass index; TC = total cholesterol; TG = triglycerides; HDL-C = high-density lipoprotein cholesterol;
LDL-C = low-density lipoprotein cholesterol; ApoA1 = Apolipoprotein A1; ApoB100 = Apolipoprotein B100;
FBG = fasting blood glucose.
https://doi.org/10.1371/journal.pone.0185261.t001
Table 2. Visual classification of 130 carotid plaques by two experienced sonographers.
Sonographer 2
Echoluent Intermediate Echo-rich Total
Sonographer 1 Echoluent 47 0 0 47
Intermediate 3 35 0 38
Echo-rich 1 1 43 45
Total 51 36 43 130
κ = 0.942.
https://doi.org/10.1371/journal.pone.0185261.t002
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E. Intra-operator agreement
Fig 4 illustrates the scatterplot of the average AUCPDC against the AUCPDC difference for 45
plaques that are analyzed at two different times within a 2-month period by one operator. Of
the 45 points, there were 41 scattered in the Mean ± 1.96 SD region (95% confidence level).
The AUCPDC analysis showed a good intra-operator agreement.
F. Relationship between GSM, AUCPDC and hypertension, diabetes,
CHD
Spearman’s rank correlation analysis was implemented to examine the relationship between
the GSM, AUCPDC and the status of hypertension, diabetes, CHD (Table 5). Compared with
GSM, the AUCPDC showed a statistical association with CHD (Spearman r = -0.121,
p = 0.315 vs. r = 0.234, p = 0.050).
G. Estimating Youden’s index J in bootstrapping samples
When bootstrap was performed to estimate the Youden’s index J, a total of 2000 bootstrapping
samples was generated. The Youden’s index J was 0.633 (95% CI: 0.479–0.753) when AUCPDC
Fig 2. The AUCPDC of representative echoluent, intermediate and echo-rich plaques. The echoluent, intermediate and echo-rich plaques
in (d) were defined in the original images (a), (b) and (c), respectively. Note that AUCPDC = area under cumulative probability distribution curve.
https://doi.org/10.1371/journal.pone.0185261.g002
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was used to train the classifier, whereas Youden’s index J was 0.492 (95% CI: 0.326–0.633)
when GSM was used.
Discussion
In the present study, the AUCPDC was proposed to evaluate plaque echogenicity. Our results
indicated that it is feasible to classify echo-rich, intermediate and echolucent plaques based on
AUCPDC. The classification accuracy was 78.4% (κ = 0.673), when AUCPDC was used to
train the classifier. Previous studies have proven that the echolucent plaque is a high risk indi-
cator of cardiovascular events [8,10,18,31,32]. Compared with GSM, the AUCPDC showed a
higher potential feasibility for identifying echolucent plaques (AUC = 0.817) (Fig 3), and it was
more related to CHD (Spearman r = 0.234, p = 0.050) (Table 5). These indicate that AUCPDC
analysis of the ultrasound images of carotid plaques might have potential in predicting the car-
diovascular risk in patients with plaques.
Many studies have shown that visual classification is a feasible and reliable method for clas-
sification of ultrasound plaques with different echogenicity [12,13,33]. Geroulakos et al. classi-
fied 70 carotid plaques into five different types (type 1 uniformly echolucent, type 2
predominantly echolucent, type 3 predominantly echogenic, type 4, uniformly echogenic, and
type 5 calcified plaques) and the between-observer reproducibility was 85.71% (κ = 0.79).
Mayor et al. analyzed 95 carotid bifurcation plaques with the same five-type classification sys-
tem, and a between-observer reproducibility of 91% (κ = 0.87) was observed. In this study, the
plaques were classified into three different types (type 1 echo-rich, type 2 intermediate and
type 3 echolucent) according to the scheme of the European carotid plaque study group [12],
and a higher between-observer reproducibility of 96.15% (κ = 0.942) was achieved.
Both GSM and AUCPDC are calculated based on the gray scale distribution. Compared
with GSM, the AUCPDC calculation takes into consideration the probability density distribu-
tion of gray scale values ranging from 0 to 255. The lower gray scale value with a high probabil-
ity density gives rise to a higher value of AUCPDC. Fig 5 illustrates that the sample 1 has a
Table 3. Classification of 125 carotid plaques based on GSM.
GSM
Echoluent Intermediate Echo-rich Total
Sonographers Echoluent 37 8 2 47
Intermediate 21 8 6 35
Echo-rich 2 5 36 43
Total 60 21 44 125
κ = 0.460.
https://doi.org/10.1371/journal.pone.0185261.t003
Table 4. Classification of 125 carotid plaques based on AUCPDC.
AUCPDC
Echoluent Intermediate Echo-rich Total
Sonographers Echoluent 37 10 0 47
Intermediate 11 21 3 35
Echo-rich 1 2 40 43
Total 49 33 43 125
κ = 0.673.
https://doi.org/10.1371/journal.pone.0185261.t004
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Fig 3. Receiver operating characteristic curves of identifying echolucent plaques for KNN classifier
using AUCPDC and GSM. Note that AUC = area under the curve; GSM = gray-scale median; AUCPDC =
area under cumulative probability distribution curve.
https://doi.org/10.1371/journal.pone.0185261.g003
Fig 4. Scatterplot of the average AUCPDC against the AUCPDC difference for 45 plaques analyzed at
2 different times within a 2-month period by one operator. Note that AUCPDC = area under cumulative
probability distribution curve.
https://doi.org/10.1371/journal.pone.0185261.g004
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same GSM with sample 2 (GSM = 128), but the AUCPDC of sample 2 is larger than sample 1.
It may imply that AUCPDC is more effective than GSM in distinguishing the differences in
the probability density distributions of gray scale value of plaques. Consistent with the above
analysis, Tables 3 and 4 indicate that AUCPDC shows an obvious superiority in discriminating
intermediate and echolucent plaques.
In this research, compared with GSM, the AUCPDC showed a statistical association with
CHD (p = 0.05) (Table 5), but the correlation is barely significant. Such results may be caused
by the relatively small sample size and sample difference. Among a total of 72 patients in this
study, only 27 (37.5%) patients had CHD. What’s more, there are some methodological limita-
tions on the calculation of AUCPDC. The ultrasound system settings (e.g. system gain, time
gain compensation etc.) impact the brightness and contrast of the B-mode images, which will
cause calculation bias in AUCPDC. To reduce the impact of instrument settings, normaliza-
tion of the dynamic range is done by considering minimum and maximum pixel intensities
within the region-of-interest. Overall, the AUCPDC is an effective parameter for evaluating
the plaque echogenicity.
Conclusion
Compared with GSM, the AUCPDC is more effective in classifying three types of plaques and
identifying echolucent plaques, suggesting that AUCPDC analysis is a promising method for
Table 5. Spearman’s rank correlation between the GSM, AUCPDC and the status of hypertension, diabetes, CHD.
Hypertension Diabetes CHD
GSM Spearman r -0.031 -0.071 -0.121
p 0.798 0.554 0.315
AUCPDC Spearman r 0.1 -0.035 .234
p 0.402 0.770 0.050*
GSM = gray-scale median; AUCPDC = area under cumulative probability distribution curve, CHD = coronary heart disease.
https://doi.org/10.1371/journal.pone.0185261.t005
Fig 5. A comparison between AUCPDC with GSM when the probability density curve is changed. Note that GSM = gray-scale median;
AUCPDC = area under cumulative probability distribution curve.
https://doi.org/10.1371/journal.pone.0185261.g005
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evaluating plaque echogenicity and predicting cardiovascular risk in patients with plaques.
However, this study is limited by the relatively small number of plaques, thus future research is
required to further validate our results. Furthermore, a longitudinal, prospective study utiliz-
ing carotid ultrasound examination in a large number of patients with atherosclerotic risk is
required to assess the value of AUCPDC in predicting the future cardiovascular events.
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